ArticleApplied biochemistry and biotechnology2025
Hyper-production and Characterization of Exoglucanase Through Physical, Chemical, and Combined Mutagenesis in Indigenous Strain of Thermophilic Aspergillus fumigatus.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- In Vitro Evaluation of Novel Synthetic Benzimidazolium-Chalcone Hybrids: Antioxidant and Regenerative Effects in Diabetic Wound Healing.Applied biochemistry and biotechnology · 2026Article
- The Effect of ARTP Mutation on the Degradation Capacity ofCurrent issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study explored the optimization of exoglucanase production from waste cellulosic biomaterials using microbial cellulases, focusing on enhancing enzyme efficiency through mutagenesis techniques. Research illustrated the hyper-production and quantitative characterization of an exoglucanase from a thermophilic Aspergillus fumigatus strain via physical and chemical mutagenesis under optimized fermentation conditions. Physical mutagenesis via UV irradiation (15-min exposure) yielded the highest activity (96.57 U/mL), while chemical mutagenesis with ethyl methane sulfonates (250 µg/mL) resulted in 69.61 U/mL activity. Combined mutagenesis using EMS (250 µg/mL) concentration with 15-min UV exposure significantly enhanced exoglucanase production to 136.19 U/mL as compared to the native enzyme 52.46 U/mL. Among various cellulosic substrates, peanut shells exhibited superior suitability for exoglucanase production reaching a maximum activity of 202.41 U/mL. Fermentation parameters including pH, temperature, incubation period, and inoculum size were optimized, leading to a substantial increase in exoglucanase activity of 285.28 U/mL using response surface methodology followed by gel filtration chromatography. The mutant exoglucanase was characterized by its enhanced activities with a higher Vmax (0.6515) and lower Km (0.3142) than those of native enzyme. The characterization has confirmed the temperature and pH tolerance of the mutant enzyme, as well as its tolerance to metal ions and substrate concentrations. This study showed how mutagenesis-driven optimization could provide a means to enhance exoglucanase production from cellulosic biomass, with a rational insight toward enzyme kinetics and applications toward bioenergy generation.
Indexed as
Identifiers
40138137What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.